Diabetes-related foot disease results in major morbidity and mortality ([@B1]). National and global amputation rates vary considerably ([@B2],[@B3]) because of confounding factors, such as ethnicity, case definition, and ascertainment of diabetes prevalence ([@B4]).The aim of this study was to establish any change in the incidence of diabetes-related nontraumatic lower-extremity amputation (LEA) in Scotland from 2004 to 2008.

RESEARCH DESIGN AND METHODS {#s1}
===========================

We performed a cohort study of all people in Scotland with diabetes between January 2004 and December 2008. The Scottish Morbidity Record was the primary data source using predefined codes for categorization of amputation type (OCPS-4 codes ×07--11). This was linked with the Scottish Care Information--Diabetes Collaboration (SCI-DC) National Diabetes Register ([@B5]).

Approval for the dataset was from SCI-DC, Scottish multicenter research ethics committee, Privacy Advisory Committee of NHS National Services Scotland, and Caldicott guardians.

An LEA was defined as a complete loss in the transverse anatomical plane of any part of the limb. Major amputation was any through or proximal to the ankle and minor distal to the ankle. In patients with more than one procedure, the highest level of amputation was analyzed. Traumatic and tumor-related amputations were excluded. A diabetes-related LEA was any in a person known to have diabetes at the time of amputation or registered with diabetes within 3 months of amputation.

The national population was taken from the General Register Office for Scotland's midpoint population estimates. The diabetes population was taken from SCI-DC. Incidence of amputation was expressed as number of amputations in people with diabetes per 1,000 individuals with diabetes and per 100,000 general population.

Chi-square test methods were used to assess changes in amputations over time. The significances of linear trends were investigated using Kendall τ~b~. This cohort study has been reported using Strengthening the Reporting of Observational Studies in Epidemiology guidance ([@B6]).

RESULTS {#s2}
=======

The Scottish diabetes population increased by 12.8% from 183,311 in 2004 to 206,818 in 2008. This represents an increase in crude prevalence of diabetes from 3.6 to 4.0%. The mean age of people with diabetes increased from 59.4 to 62.7 years from 2004 to 2008. Diabetes duration increased from 7.6 to 8.7 years over 5 years. Other parameters including HbA~1c~, BMI, and estimated glomerular filtration rate remained stable.

Two thousand three hundred eighty-two people with diabetes underwent nontraumatic LEAs between 2004 and 2008. The number of people undergoing major and minor amputations over 5 years were 1,359 and 1,023, respectively ([Table 1](#T1){ref-type="table"}). This corresponded to a total, major, and minor amputation rate of 2.42, 1.39, and 1.04 per 1,000 individuals with diabetes per year, respectively.
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The incidence of major and total amputations (per 1,000 of the diabetes population) fell steadily over 5 years (*P* \< 0.001). There was a 29.8% reduction in individuals with diabetes undergoing any LEA from 3.04 to 2.13 per 1,000. The most pronounced fall was in major LEAs, with a reduction of 40.7% from 1.87 per 1,000 in 2004 to 1.11 per 1,000 in 2008. There was a 1.7-fold variation in diabetes-related amputation rates between different health boards (range 1.1--1.9%, *P* \< 0.001).

The incidence of diabetes-related amputations per 100,000 of the general population fell by 22.2% from 10.97 to 8.53. The decreasing trend was statistically significant for major and total (*P* \< 0.001 in both cases) but not minor amputations. The largest fall was in those undergoing major LEAs, in which there was a reduction of 34.2% from 6.73 to 4.43 per 100,000 from 2004 to 2008.

CONCLUSIONS {#s3}
===========

The incidence of LEA in persons with diabetes in Scotland has decreased by 30% over 5 years. The greatest reduction was in major amputation, which fell by 41%.

A potential confounding factor contributing to the decreased incidence of amputations in our study could be improved registration of diabetes rather than a true increase in the prevalence of new cases. Establishing accurate amputation incidence is difficult because of variability in the denominator and misclassification of cases ([@B7]). Although it is important to consider case ascertainment, it is unlikely to be a major factor in our study because the Scottish information system for diabetes diagnosis has been established for a number of years, and the annual increase in prevalence of 0.2% indicates an established stable population.

Because amputation rates are susceptible to many confounding variables, it has been suggested that to demonstrate a genuine improvement both incidence and absolute number of amputations should fall ([@B4]). We have shown both to be the case and feel that the decrease in amputation rate is therefore genuine. Several regional studies have demonstrated significant reductions in diabetes-related amputations ([@B8]--[@B10]); however, this is not reflected at a national level ([@B11],[@B12]). Further studies have shown significant geographic variation within countries ([@B13]) and highlight the benefit of national data in determining accurate amputation rates.

Countries that have shown a reduction in diabetes-related amputations include the Netherlands ([@B2]), Finland ([@B14]), and the U.S. ([@B15]), with a decrease in total amputations of 37, 49, and 65%, respectively. These studies were hampered with methodological problems, including estimates from a projected diabetes population, failure to provide the incidence for amputation subtypes, and reporting relative risk compared with nondiabetic subjects. This raises the possibility that a significant proportion of any decrease was a result of diabetes case ascertainment or an increased rate of amputation in people without diabetes. These studies highlight the problems of comparing amputation rates when the number of subjects in the denominator changes significantly or there is failure to report transparent data on amputation types. There is an urgent need to devise a consistent approach to reporting amputation incidence. Similar to others ([@B4]), we would advocate that total, major, and minor amputation incidences are reported per 1,000 subjects with diabetes and per 100,000 of the general population. This would allow comparisons between countries, and inclusion of general population rates helps negate any numerator/denominator bias relating to identification of diabetes cases.

We believe that Scotland is the fourth nation to show a significant reduction in the incidence of diabetes-related LEAs. However, Scotland is the first to provide information on amputation subtypes and rates from an actual rather than estimated diabetes population.

See accompanying commentary, p. 2419.
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